Masimo (NASDAQ: MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on Tuesday, March 4, 2025 at 11:35 a.m. Eastern time. A ...

Masimo (NASDAQ:MASI – Get Free Report) had its price objective upped by equities researchers at Piper Sandler from $210.00 to $215.00 in a report released on Wednesday,Benzinga reports. The brokerage ...

Masimo (MASI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Wells Fargo raised the firm’s price target on Masimo (MASI) to $205 from $193 and keeps an Overweight rating on the shares. The firm is ...

Sigma Planning Corp lifted its stake in Masimo Co. (NASDAQ:MASI – Free Report) by 21.7% during the fourth quarter, Holdings ...

Let’s take a look at how patient monitoring stocks fared in Q4, starting with DexCom (NASDAQ:DXCM). Patient monitoring companies within the healthcare equipment industry offer devices and technologies ...

Masimo stock surged Wednesday on its upbeat earnings and 2025 outlook, though one analyst cautioned cost reductions could ...

Masimo Corporation MASI delivered adjusted earnings per share (EPS) of $1.80 in the fourth quarter of 2024, up 44% year over ...

Masimo says strategic realignment efforts near the end of last year increased the digital health pioneer's earnings power.

BTIG analyst Marie Thibault raised the firm’s price target on Masimo (MASI) to $206 from $178 and keeps a Buy rating on the shares after its Q4 ...

Shares of Health Care sector company Masimo moved 10.5% today, and are now trading at a price of $187.31. The Large-Cap stock ...

Masimo Corporation’s MASI share price has surged by 12.35%, which has investors questioning if this is right time to sell.